Roberts Laura Weiss, Hammond Katherine Green, Hoop Jinger
Department of Family and Community Medicine, University of New Mexico School of Medicine, Albuquerque, Milwaukee, WI 53226, USA.
Am J Psychiatry. 2006 Nov;163(11):2002-4. doi: 10.1176/ajp.2006.163.11.2002.
This study attempted to clarify how people with schizophrenia evaluate the potential harm associated with various research-related procedures and how these assessments relate to participation willingness.
The authors conducted a semistructured interview among participants with schizophrenia.
Sixty participants with schizophrenia rated four procedures as harmful (e.g., symptom induction), five procedures as moderately harmful (e.g., being given a placebo), and six procedures as not harmful (e.g., undergoing a physical examination). Rated willingness to participate was inversely related to the participants' perceptions of harmfulness for all procedures.
In this study, people living with schizophrenia perceived different research procedures as posing different levels of possible harm. Potential harm appears to be an important consideration in protocol enrollment decisions. This work reaffirms the value of clarifying the strengths of seriously ill people who may choose to participate in research.
本研究试图阐明精神分裂症患者如何评估与各种研究相关程序相关的潜在危害,以及这些评估与参与意愿之间的关系。
作者对精神分裂症患者进行了半结构化访谈。
60名精神分裂症患者将四种程序评为有害(例如症状诱发),五种程序评为中度有害(例如给予安慰剂),六种程序评为无害(例如接受体格检查)。所有程序的参与意愿评分与参与者对有害性的认知呈负相关。
在本研究中,精神分裂症患者认为不同的研究程序会带来不同程度的潜在危害。潜在危害似乎是方案入组决策中的一个重要考虑因素。这项工作重申了明确可能选择参与研究的重症患者优势的价值。